Entity Details

Primary name OPA3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9H6K4
EntryNameOPA3_HUMAN
FullNameOptic atrophy 3 protein
TaxID9606
Evidenceevidence at protein level
Length179
SequenceStatuscomplete
DateCreated2002-03-27
DateModified2021-06-02

Ontological Relatives

GenesOPA3

GO terms

Show/Hide Table
GOName
GO:0005739 mitochondrion
GO:0007601 visual perception
GO:0019216 regulation of lipid metabolic process
GO:0050896 response to stimulus

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion

Domains

Show/Hide Table
DomainNameCategoryType
IPR010754 Optic atrophy 3-likeFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
165300 OMIMOptic atrophy 3 (OPA3)A condition that features progressive visual loss in association with optic atrophy. Atrophy of the optic disk indicates a deficiency in the number of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. OPA3 is associated with cataract and a neurologic disorder characterized by extrapyramidal signs and ataxia. The disease is caused by variants affecting the gene represented in this entry.
258501 OMIM3-methylglutaconic aciduria 3 (MGCA3)An autosomal recessive metabolic disorder that causes a neuro-ophthalmologic syndrome consisting of early-onset bilateral optic atrophy, spasticity, extrapyramidal dysfunction and cognitive deficit. Urinary excretion of 3-methylglutaconic acid and 3-methylglutaric acid is increased. MGCA3 can be distinguished from MGCA1 by the absence of increase of 3-hydroxyisovaleric acid levels. The disease is caused by variants affecting the gene represented in this entry.

Interactions

6 interactions